RecruitingPhase 2NCT07572383

Advanced Imaging to Assess the Effect of Immunosuppression on Progressive Fibrosis

Studying Idiopathic pulmonary fibrosis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Peter Caravan
Principal Investigator
Sydney Montesi, MD
Massachusetts General Hospital
Intervention
[68Ga]CBP8(drug)
Enrollment
15 target
Eligibility
18-80 years · All sexes
Timeline
2026 – 2028

Study locations (1)

Collaborators

National Heart, Lung, and Blood Institute (NHLBI)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07572383 on ClinicalTrials.gov

Other trials for Idiopathic pulmonary fibrosis

Additional recruiting or active studies for the same condition.

See all trials for Idiopathic pulmonary fibrosis →

← Back to all trials